These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35529445)

  • 41. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
    Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug properties and host factors contribute to biochemical presentation of drug-induced liver injury: a prediction model from a machine learning approach.
    Gonzalez-Jimenez A; Suzuki A; Chen M; Ashby K; Alvarez-Alvarez I; Andrade RJ; Lucena MI
    Arch Toxicol; 2021 May; 95(5):1793-1803. PubMed ID: 33666709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical characteristics of drug-induced liver injury and related risk factors.
    Lu RJ; Zhang Y; Tang FL; Zheng ZW; Fan ZD; Zhu SM; Qian XF; Liu NN
    Exp Ther Med; 2016 Oct; 12(4):2606-2616. PubMed ID: 27703513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of DILI Predictive Hypotheses in Early Drug Development.
    Chan R; Benet LZ
    Chem Res Toxicol; 2017 Apr; 30(4):1017-1029. PubMed ID: 28257576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the Relevance of DILI Predictive Hypotheses in Early Drug Development: Review of
    Chan R; Benet LZ
    Toxicol Res (Camb); 2018 May; 7(3):358-370. PubMed ID: 29785262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationships between the Structure and Severe Drug-Induced Liver Injury for Low, Medium, and High Doses of Drugs.
    Ivanov SM; Lagunin AA; Filimonov DA; Poroikov VV
    Chem Res Toxicol; 2022 Mar; 35(3):402-411. PubMed ID: 35172101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
    Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
    J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.
    Lammert C; Einarsson S; Saha C; Niklasson A; Bjornsson E; Chalasani N
    Hepatology; 2008 Jun; 47(6):2003-9. PubMed ID: 18454504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
    Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
    Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antifungal Drugs and Drug-Induced Liver Injury: A Real-World Study Leveraging the FDA Adverse Event Reporting System Database.
    Zhou ZX; Yin XD; Zhang Y; Shao QH; Mao XY; Hu WJ; Shen YL; Zhao B; Li ZL
    Front Pharmacol; 2022; 13():891336. PubMed ID: 35571077
    [No Abstract]   [Full Text] [Related]  

  • 52. Anxiety and Its Influencing Factors in Patients With Drug-Induced Liver Injury.
    Liu YH; Guo Y; Xu H; Feng H; Chen DY
    Front Psychol; 2022; 13():889487. PubMed ID: 35837621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. InterDILI: interpretable prediction of drug-induced liver injury through permutation feature importance and attention mechanism.
    Lee S; Yoo S
    J Cheminform; 2024 Jan; 16(1):1. PubMed ID: 38173043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).
    Minerali E; Foil DH; Zorn KM; Lane TR; Ekins S
    Mol Pharm; 2020 Jul; 17(7):2628-2637. PubMed ID: 32422053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).
    Pedersen JM; Matsson P; Bergström CA; Hoogstraate J; Norén A; LeCluyse EL; Artursson P
    Toxicol Sci; 2013 Dec; 136(2):328-43. PubMed ID: 24014644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.
    Oda S; Uchida Y; Aleo MD; Koza-Taylor PH; Matsui Y; Hizue M; Marroquin LD; Whritenour J; Uchida E; Yokoi T
    Arch Toxicol; 2021 Jan; 95(1):149-168. PubMed ID: 32816093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury.
    Shimizu Y; Sasaki T; Yonekawa E; Yamazaki H; Ogura R; Watanabe M; Hosaka T; Shizu R; Takeshita JI; Yoshinari K
    J Toxicol Sci; 2021; 46(4):167-176. PubMed ID: 33814510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs.
    Hong H; Thakkar S; Chen M; Tong W
    Sci Rep; 2017 Dec; 7(1):17311. PubMed ID: 29229971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insights into mechanisms and severity of drug-induced liver injury via computational systems toxicology approach.
    Peng Y; Wu Z; Yang H; Cai Y; Liu G; Li W; Tang Y
    Toxicol Lett; 2019 Sep; 312():22-33. PubMed ID: 31063831
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minimizing DILI risk in drug discovery - A screening tool for drug candidates.
    Schadt S; Simon S; Kustermann S; Boess F; McGinnis C; Brink A; Lieven R; Fowler S; Youdim K; Ullah M; Marschmann M; Zihlmann C; Siegrist YM; Cascais AC; Di Lenarda E; Durr E; Schaub N; Ang X; Starke V; Singer T; Alvarez-Sanchez R; Roth AB; Schuler F; Funk C
    Toxicol In Vitro; 2015 Dec; 30(1 Pt B):429-37. PubMed ID: 26407524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.